i'm gonna nutshell this one as best as I can
in 2011 MSB had a Phase 3 product. it got mothballed, why?
it was relegated to Tier 2? okay, but it was Phase 3 - 6 years ago!
MSB had never commercialised a product, had no revenue to speak of but they mothballed it. Why?
Even if it was only Tier 2, it was closest to monetising and would have been AMAZING practice for commercialising a later Tier 1 - logisitics, supply chain, licensing, negotiating the final stages of FDA - do it on something that works but isn't stratospheric. but they mothballed it.
And now we wait, and spend... on "hopefullys"
Back pain stem cell injection, page-54
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.495B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.819M | 1.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29972 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 2008 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |